Supernus Pharmaceuticals (SUPN) Stock Forecast & Price Target

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

$29.00

-0.43 (-1.46%)

(As of 04/17/2024 ET)

Supernus Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 1 Analyst Ratings

Analysts' Consensus Price Target

$41.00
41.38% Upside

High Forecast	$41.00
Average Forecast	$41.00
Low Forecast	$41.00

Type	Current Forecast 4/19/23 to 4/18/24	1 Month Ago 3/20/23 to 3/19/24	3 Months Ago 1/19/23 to 1/19/24	1 Year Ago 4/19/22 to 4/19/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$41.00	$41.00	$43.00	$47.00
Predicted Upside	41.38% Upside	37.63% Upside	64.75% Upside	16.60% Upside

Get Supernus Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter.

Ad Priority Gold

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

SUPN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SUPN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Supernus Pharmaceuticals Stock vs. The Competition

Type	Supernus Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.68	2.49
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	41.38% Upside	923.17% Upside	12.15% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
2/28/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$45.00 ➝ $41.00	+37.63%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:32 AM ET.

SUPN Price Target - Frequently Asked Questions

What is Supernus Pharmaceuticals's consensus rating and price target?: According to the issued ratings of 1 analysts in the last year, the consensus rating for Supernus Pharmaceuticals stock is Buy based on the current 1 buy rating for SUPN. The average twelve-month price prediction for Supernus Pharmaceuticals is $41.00 with a high price target of $41.00 and a low price target of $41.00. Learn more on SUPN's analyst rating history.
Do Wall Street analysts like Supernus Pharmaceuticals more than its competitors?: Analysts like Supernus Pharmaceuticals more than other Medical companies. The consensus rating for Supernus Pharmaceuticals is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how SUPN compares to other companies.
Does Supernus Pharmaceuticals's stock price have much upside?: According to analysts, Supernus Pharmaceuticals's stock has a predicted upside of 37.63% based on their 12-month stock forecasts.

What analysts cover Supernus Pharmaceuticals?: Supernus Pharmaceuticals has been rated by Piper Sandler in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:SUPN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Supernus Pharmaceuticals (SUPN) Stock Forecast & Price Target

Supernus Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

SUPN Analyst Ratings By Month

SUPN Price Targets by Month

Supernus Pharmaceuticals Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

SUPN Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info